THAT’S DISAPPOINTING: Alzheimer’s drug crenezumab has disappointing results in clinical trial.
InstaPundit is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.